Regenerx Financial Statements From 2010 to 2024

RGRXDelisted Stock  USD 0.03  0.01  25.00%   
Regenerx Biopharm financial statements provide useful quarterly and yearly information to potential Regenerx Biopharm In investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Regenerx Biopharm financial statements helps investors assess Regenerx Biopharm's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Regenerx Biopharm's valuation are summarized below:
Regenerx Biopharm In does not presently have any trending fundamental ratios for analysis.
Check Regenerx Biopharm financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Regenerx Biopharm's main balance sheet or income statement drivers, such as , as well as many indicators such as . Regenerx financial statements analysis is a perfect complement when working with Regenerx Biopharm Valuation or Volatility modules.
  
This module can also supplement various Regenerx Biopharm Technical models . Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Regenerx Biopharm In OTC Stock Return On Asset Analysis

Regenerx Biopharm's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Return On Asset

 = 

Net Income

Total Assets

More About Return On Asset | All Equity Analysis

Current Regenerx Biopharm Return On Asset

    
  -0.84  
Most of Regenerx Biopharm's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Regenerx Biopharm In is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Competition

Based on the latest financial disclosure, Regenerx Biopharm In has a Return On Asset of -0.8397. This is 90.4% lower than that of the Biotechnology sector and 96.44% lower than that of the Health Care industry. The return on asset for all United States stocks is notably higher than that of the company.

Regenerx Biopharm Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Regenerx Biopharm's current stock value. Our valuation model uses many indicators to compare Regenerx Biopharm value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Regenerx Biopharm competition to find correlations between indicators driving Regenerx Biopharm's intrinsic value. More Info.
Regenerx Biopharm In is rated second in return on asset category among its peers. It is currently regarded as top stock in operating margin category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Regenerx Biopharm by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Regenerx Biopharm's OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

About Regenerx Biopharm Financial Statements

Regenerx Biopharm investors use historical fundamental indicators, such as Regenerx Biopharm's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Regenerx Biopharm. Please read more on our technical analysis and fundamental analysis pages.
RegeneRx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of therapeutic peptide, thymosin beta 4, for tissue and organ protection, repair, and regeneration. RegeneRx Biopharmaceuticals, Inc. was incorporated in 1982 and is based in Rockville, Maryland. REGENERX BIOPHARMACEUTICA operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 3 people.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Consideration for investing in Regenerx OTC Stock

If you are still planning to invest in Regenerx Biopharm check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Regenerx Biopharm's history and understand the potential risks before investing.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.